The latest brain, head and neck cancer news
Immunotherapies that activate T cells to eliminate cancer cells have shown limited efficacy as standalone…
Human papillomavirus (HPV) can drive tumour development in some rare sinonasal squamous cell carcinomas (SNSCCs),…
An immunotherapy helps patients live years longer without their cancer getting worse or coming back,…
Results from the international phase 3 NIVOPOSTOP clinical trial found that adding nivolumab to chemoradiotherapy…
A dual-target CAR T cell therapy approach shows promise for slowing tumour growth in glioblastoma. Tumours became…
Researchers report that ‘HPV-DeepSeek’ was highly accurate in detecting HPV-associated head and neck cancers in…
Findings related to the common anti-seizure and neuropathic pain drug offer new hope for extending…
Medulloblastoma, the most common malignant paediatric brain tumour, presents substantial clinical challenges due to its…
Oral squamous cell carcinoma (OSCC) progresses from seemingly benign preneoplastic lesions, but understanding the epigenetic…
The most prevalent malignant brain tumour in adults – glioblastoma (GBM) – is an aggressive…